Experiment 1158404
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | BLAYNEY,DW: GLODBERG,DA: LEONG,LA: CARR,BI: DOROSHOW,JH:. (1986). PHASE II TRIAL OF ESORUBICIN IN ADVANCED PANCREATIC ADENOCARCINOMA.. 70(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II TRIAL, EIGHTEEN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA WERE TREATED. DOSES WERE REPEATED EVERY 3-4 WEEKS. THERE WERE NO OBJECTIVE CLINICAL OR RADIOGRAPHIC RESPONSES. GRANULOCYTE TOXICITY WAS DOSE LIMITING AT 42 MG/SQ.M. WITH ALL PATIENTS DEVELOPING AT LEAST GRADE 3 LEUKOPENIA. THROMBOCYTOPENIA, NAUSEA AND VOMITING, AND ALOPECIA WERE MILD (GRADE 2 OR LESS). THERE WERE 2 CASES OF CARDIAC TOXICITY. |
| Dose amount | 20.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |